文献速递肺栓塞与肺血管病

梗阻性肥厚型心肌病合并肺动脉高压的晚期肺血管重塑证据

Evidence of Advanced Pulmonary Vascular Remodeling in Obstructive Hypertrophic Cardiomyopathy With Pulmonary Hypertension.
PubMed 文献 · Chest · 2022-10-13

该研究回顾性分析7例梗阻性肥厚型心肌病(HCM)患者尸检肺组织及5例对照,发现HCM患者存在显著肺小动脉肥厚、纤维化及肺静脉增厚,且与平均肺动脉压、肺楔压及左室流出道压差相关,提示即使mPAP轻度升高也伴病理性肺血管重塑。

要点

  • 梗阻性HCM患者肺血管存在显著结构重塑,包括动脉肥厚、纤维化及静脉增厚。
  • 肺血管重塑指标与mPAP、PAWP及左室流出道压差相关。
  • 即使mPAP仅轻度升高,也应关注HCM相关肺血管病变。

核心结论

  • 梗阻性HCM患者心衰与致病性肺血管重塑相关,即使mPAP仅轻度升高。

研究设计与样本

  • 回顾性研究,获取美国国立卫生研究院1975-1992年罕见肺尸检标本,HCM组7例,对照为被拒供肺组织5例。
  • HCM组平均年龄43±18岁,男性占71%,最大左室壁厚度25±2.8 mm,流出道压差90±30 mm Hg。
  • 中位mPAP 25 mm Hg(IQR 6),中位PAWP 16 mm Hg(IQR 4),中位肺血管阻力1.8 WU(IQR 2.4)。
  • 对肺小动脉和静脉进行组织形态学分析,采用t检验、Mann-Whitney U检验及Pearson相关。

主要发现

  • HCM组肺小动脉肥厚指数20.7±7.2% vs 对照49.7±12%(P < .001),动脉壁纤维化11.5±3.4 mm vs 21.0±4.7 mm(P < .0001)。
  • 肺小动脉肥厚与mPAP(r = 0.84;P = .018)、PAWP(r = 0.74;P = .05)及左室流出道压差(r = 0.78;P = .035)相关。
  • HCM组肺静脉厚度较对照增加2.9倍(P = .008),与mPAP(r = 0.81;P = .03)及左室流出道压差(r = 0.83;P = .02)相关。

临床怎么用

  • 对梗阻性HCM合并心衰患者,即使mPAP轻度升高,也应警惕肺血管重塑。
  • 未来临床策略可考虑减轻左室流出道梗阻以干预肺血管病变。

局限性

  • 样本量小(HCM组7例,对照5例),为回顾性分析。
  • 使用罕见尸检标本,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Elevated mean pulmonary artery pressure (mPAP) is common in patients with hypertrophic cardiomyopathy (HCM) and heart failure symptoms. However, dynamic left ventricular (LV) outflow tract obstruction may confound interpretation of pulmonary hypertension (PH) pathophysiologic features in HCM when relying on resting invasive hemodynamic data alone. RESEARCH QUESTION: Do structural changes to the lung vasculature clarify PH pathophysiologic features in patients with HCM with progressive heart failure? STUDY DESIGN AND METHODS: Clinical data and ultrarare lung autopsy specimens were acquired retrospectively from the National Institutes of Health (1975-1992). Patients were included based on the availability of lung tissue and recorded mPAP. Discarded tissue from rejected lung donors served as control specimens. Histomorphology was performed on pulmonary arterioles and veins. Comparisons were calculated using the Student t test and Mann-Whitney U test; Pearson correlation was used to assess association between morphometric measurements and HCM cardiac and hemodynamic measurements. RESULTS: The HCM cohort (n = 7; mean ± SD age, 43 ± 18 years; 71% men) showed maximum mean ± SD LV wall thickness of 25 ± 2.8 mm, mean ± SD outflow tract gradient of 90 ± 30 mm Hg, median mPAP of 25 mm Hg (interquartile range [IQR], 6 mm Hg), median pulmonary artery wedge pressure (PAWP) of 16 mm Hg (IQR, 4 mm Hg), and median pulmonary vascular resistance of 1.8 Wood units (WU; IQR, 2.4 WU). Compared with control samples (n = 5), patients with HCM showed greater indexed pulmonary arterial hypertrophy (20.7 ± 7.2% vs 49.7 ± 12%; P < .001) and arterial wall fibrosis (11.5 ± 3.4 mm vs 21.0 ± 4.7 mm; P < .0001), which correlated with mPAP (r = 0.84; P = .018), PAWP (r = 0.74; P = .05), and LV outflow tract gradient (r = 0.78; P = .035). Compared with control samples, pulmonary vein thickness was increased by 2.9-fold (P = .008) in the HCM group, which correlated with mPAP (r = 0.81; P = .03) and LV outflow tract gradient (r = 0.83; P = .02). INTERPRETATION: To the best of our knowledge, these data demonstrate for the first time that in patients with obstructive HCM, heart failure is associated with pathogenic pulmonary vascular remodeling even when mPAP is elevated only mildly. These observations clarify PH pathophysiologic features in HCM, with future implications for clinical strategies that mitigate outflow tract obstruction.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Maron BA, Kleiner DE, Arons E, et al. Evidence of Advanced Pulmonary Vascular Remodeling in Obstructive Hypertrophic Cardiomyopathy With Pulmonary Hypertension. Chest. 2022. PMID: 36243062. doi:10.1016/j.chest.2022.09.040

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。